Horizon Therapeutics (BSP:H1ZN34) Shares Buyback Ratio % : 1.34 (As of May. 06, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Horizon Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Horizon Therapeutics's current shares buyback ratio was 1.34%.

Horizon Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Horizon Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Horizon Therapeutics Shares Buyback Ratio % Chart

Horizon Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Shares Buyback Ratio %

Get a 7-Day Free Trial

-2.71

-11.35

-17.72

-2.73

0.06

Horizon Therapeutics Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Shares Buyback Ratio %	Get a 7-Day Free Trial															-0.37	0.71	0.63	-	-

Horizon Therapeutics Shares Buyback Ratio % Calculation

Horizon Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2021 )	-	Shares Outstanding (EOP) (A: Dec. 2022 ))	/	Shares Outstanding (EOP) (A: Dec. 2021 )
	=	(2273.77	-	2272.42)	/	2273.77
	=	0.06%

Horizon Therapeutics's Shares Buyback Ratio for the quarter that ended in Jun. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Mar. 2023 )	-	Shares Outstanding (EOP) (A: Jun. 2023 ))	/	Shares Outstanding (EOP) (A: Mar. 2023 )
	=	(2272.42	-	2272.42)	/	2272.42
	=	0.00%

Horizon Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Horizon Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Horizon Therapeutics (BSP:H1ZN34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Horizon Therapeutics PLC (BSP:H1ZN34) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

70 St. Stephen’s Green, Dublin, IRL, D02 E2X4

Website

https://www.horizontherapeutics.com

Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.

Horizon Therapeutics (BSP:H1ZN34) Headlines

No Headlines